Hybrid: US FDA / UK MHRA / HC Symposium – Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice
Date
Time
Location
Organizer
Hybrid: US FDA / UK MHRA / HC Symposium – Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice
Health Canada, UK MHRA (Medicines and Healthcare products Regulatory Agency), US FDA (U.S. Food and Drug Administration)
Event Categories
Venue
Registration Link
Hybrid: US FDA / UK MHRA / HC Symposium – Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice
Registration is now open for the 5th US-FDA / MHRA-UK / Health Canada Symposium on Regulatory Perspectives in Good Clinical Practice, Bioequivalence, and Good Pharmacovigilance Practice.
This hybrid event brings together international regulators and stakeholders to explore evolving regulatory perspectives and best practices in clinical research and pharmacovigilance.
Event Details
June 2–4, 2026
Hybrid: Library and Archives Canada, Ottawa + Virtual
Free registration
For full agenda and registration details, please visit the Symposium website.
The registration announcement is also available on Health Canada’s LinkedIn page.
More Upcoming Events
